Inspiratory muscle therapy
Device6 weeks of inspiratory muscle therapy
Other names: No other interventions. Subjects will serve as their own control; single arm study.
NCT Number: NCT03339466
Individuals who have undergone the Fontan procedure are uniquely dependent upon respiratory mechanics to support pulmonary blood flow (PBF). The investigators hypothesized that enhanced respiratory muscle function via inspiratory muscle training (IMT) would improve performance on cardiopulmonary exercise stress testing (CPET).
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Adult Fontan subjects were recruited from 2 academic medical centers. Following characterization of pulmonary function and functional class, CPET was performed using incremental and constant work rate protocols. Subjects performed 6-8 weeks of IMT using a handheld inspiratory loading device (Threshold®, Philips); both exercise tests were then repeated. Patient-centered outcome data were collected before and after IMT (RAND-36 assessment and New York Heart Association (NYHA) functional class).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Single ventricle physiology status post Fontan palliation
Exclusion criteria
6 weeks of inspiratory muscle therapy
Other names: No other interventions. Subjects will serve as their own control; single arm study.
Time frame: 6-8 weeks
Peak VO2 and endurance time are the primary outcome measures
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Other
A Pilot Study of Inspiratory Muscle Function and the Effects of Inspiratory Muscle Training in Subjects With Fontan Physiology
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04901975
Cardiovascular Abnormalities, Cardiovascular Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04195451
Cardiovascular Abnormalities, Cardiovascular Diseases
Palo Alto, California, United States
View Trial DetailsNCT05634226
Cardiovascular Abnormalities, Cardiovascular Diseases
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05034354
Biventricular Congestive Heart Failure, Cardiovascular Abnormalities
Edmonton, Alberta, Canada
View Trial Details